PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2015-04-15

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1152/ajplung.00184.2014PMID 25659900PMCID PMC4398873
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin II upregulates K(Ca)3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts.

  2013cited by this paper
• Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress.

  2013cited by this paper
• β‐Adrenergic receptors stimulate interleukin‐6 production through Epac‐dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts

  2012cited by this paper
• Sdc1 Overexpression Inhibits the p38 MAPK Pathway and Lessens Fibrotic Ventricular Remodeling in MI Rats

  2012cited by this paper
• Differential p38-dependent signalling in response to cellular stress and mitogenic stimulation in fibroblasts

  2012cited by this paper
• Induction of Heme Oxygenase-1 Inhibits Cell Death in Crotonaldehyde-Stimulated HepG2 Cells via the PKC-δ -p38 -Nrf2 Pathway

  2012cited by this paper
• The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study

  2012cited by this paper
• IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway.

  2012cited by this paper
• Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.

  2011cited by this paper
• Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses.

  2011cited by this paper
• Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of pulmonary hypertension.

  2011cited by this paper
• Cyclic mechanical strain causes cAMP-response element binding protein activation by different pathways in cardiac fibroblasts

  2010cited by this paper
• Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats

  2010cited by this paper
• Protein kinase C mRNA and protein expressions in hypobaric hypoxia‐induced cardiac hypertrophy in rats

  2010cited by this paper
• Stimulation of adenosine A2B receptors induces interleukin‐6 secretion in cardiac fibroblasts via the PKC‐δ–P38 signalling pathway

  2010cited by this paper
• Cardiac Fibroblast: The Renaissance Cell

  2009cited by this paper
• p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age.

  2009cited by this paper
• The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension.

  2009cited by this paper
• PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.

  2009cited by this paper
• High glucose suppresses expression of equilibrative nucleoside transporter 1 (ENT1) in rat cardiac fibroblasts through a mechanism dependent on PKC‐ζ and MAP kinases

  2008cited by this paper
• PKC isozymes in chronic cardiac disease: possible therapeutic targets?

  2008cited by this paper
• Structural basis of protein kinase C isoform function.

  2008cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007cited by this paper
• α2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts

  2005cited by this paper
• Inactivation of 14-3-3 protein exacerbates cardiac hypertrophy and fibrosis through enhanced expression of protein kinase C beta 2 in experimental diabetes.

  2005cited by this paper
• The right ventricle in pulmonary hypertension

  2005cited by this paper
• c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo

  2005cited by this paper
• Increased Collagen Deposition and Diastolic Dysfunction but Preserved Myocardial Hypertrophy After Pressure Overload in Mice Lacking PKC&egr;

  2005cited by this paper
• Structure and regulation of MAPK phosphatases.

  2004cited by this paper
• Inhibitors of Protein Kinase Signaling Pathways: Emerging Therapies for Cardiovascular Disease

  2004cited by this paper
• Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy

  2004cited by this paper
• Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

  2003cited by this paper
• Transforming Growth Factor- β Stabilizes Elastin mRNA by a Pathway Requiring Active Smads, Protein Kinase C- δ , and p38

  2002cited by this paper
• Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.

  2002cited by this paper
• Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38.

  2002cited by this paper
• Phosphorylation of NFATc4 by p38 Mitogen-Activated Protein Kinases

  2002cited by this paper
• Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy

  2002cited by this paper
• Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts.

  2001cited by this paper
• The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy

  2001cited by this paper
• Recruitable ACE and tissue repair in the infarcted heart

  2000cited by this paper
• Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade.

  1999cited by this paper
• Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.

  1999cited by this paper
• Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension.

  1997cited by this paper
• MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway

  1996cited by this paper
• Protein Kinase C in Angiotensin II Signalling in Neonatal Rat Cardiac Fibroblasts

  1995cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper

• Calcium Signaling in Cardiac Fibroblasts: Roles in Fibrosis and Therapeutic Implications

  2025cites this paper
• Computational modelling of cardiac fibroblast signalling reveals a key role for Ca2+ in driving atrial fibrillation-associated fibrosis.

  2025cites this paper
• Inhibition of PKC-δ retards kidney fibrosis via inhibiting cGAS-STING signaling pathway in mice

  2024cites this paper
• Endoplasmic reticulum stress contributes to cisplatin-induced chronic kidney disease via the PERK–PKCδ pathway

  2022cites this paper
• Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1–7)-Mas Axis in Pulmonary Arterial Hypertension

  2021cites this paper
• Angiotensin-II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.

  2021cites this paper
• MicroRNA-21 regulates right ventricular remodeling secondary to pulmonary arterial pressure overload.

  2021cites this paper
• Endurance exercise training in pulmonary hypertension increases skeletal muscle electron transport chain supercomplex assembly

  2020cites this paper
• Oxidative Stress, Kinase Activity and Inflammatory Implications in Right Ventricular Hypertrophy and Heart Failure under Hypobaric Hypoxia

  2020cites this paper
• PKCβ/NF-κB pathway in diabetic atrial remodeling

  2020cites this paper
• Extraneural CGRP Upregulates TGF-β1 through RAMP1 Signaling during Mechanical Stretch in Kidney Proximal Tubule Epithelial Cells

  2020cites this paper
• Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.

  2019cites this paper
• Computational Model Predicts Paracrine and Intracellular Drivers of Fibroblast Phenotype After Myocardial Infarction

  2019cites this paper
• Role of phospholipase D in bleomycin-induced mitochondrial reactive oxygen species generation, mitochondrial DNA damage and pulmonary fibrosis.

  2019cites this paper
• Sensory nerve-derived neuropeptides accelerate the development and fibrogenesis of endometriosis

  2019cites this paper
• Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

  2018cites this paper
• The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension

  2018influential citation
• Activation of the sweet taste receptor, T1R3, by the artificial sweetener sucralose regulates the pulmonary endothelium

  2017cites this paper
• The impact of obesity in the cardiac lipidome and its consequences in the cardiac damage observed in obese rats.

  2017cites this paper
• Effect of α7 nicotinic acetylcholine receptor activation on cardiac fibroblasts: a mechanism underlying RV fibrosis associated with cigarette smoke exposure.

  2017cites this paper
• Effect of (cid:2) 7 nicotinic acetylcholine receptor activation on cardiac fibroblasts: a mechanism underlying RV fibrosis associated with cigarette smoke exposure

  2017influential citation
• Update on novel targets and potential treatment avenues in pulmonary hypertension.

  2016cites this paper
• Transcriptional control of cardiac fibroblast plasticity.

  2016cites this paper